Psychedelics Advocates Launch Political Action Committee

46w
4m read
Summary

A group of psychedelics activists has formed a political action committee aimed at lobbying Congress to support research into the therapeutic use of compounds including psilocybin, MDMA and ketamine. Cory Booker would create a pathway for psychedelics including psilocybin to be reclassified as Schedule II drugs instead of the more restrictive Schedule I they are currently listed under. The Psychedelic Medicine PAC points to the adoption of psilocybin legalization measures by voters in Oregon and Colorado as evidence that such reform is warranted at the federal level. Lavasani has personally experienced the benefits of psychedelics after using the promising drugs to treat post-partum depression and chronic pain. The leadership of the new PAC believes that before psychedelics can be legalized at the federal level, time must be spent educating members of Congress and the executive branch about the therapeutic potential of the compounds.

Article Preview

A group of psychedelics activists has formed a political action committee aimed at lobbying Congress to support research into the therapeutic use of compounds including psilocybin, MDMA and ketamine. The new group, dubbed the Psychedelic Medicine PAC, also plans to encourage lawmakers to ease restrictions on the powerful drugs, which have shown promise as potential treatments for mental health conditions including depression, anxiety and addiction.

“With the growing evidence of therapeutic benefits from psychedelics, we believe it is time for the American people to take action into their own hands by electing leaders that support policies that expand...

Read the full article @ High Times